Navigation Links
TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm
Date:8/21/2008

:

"We believe that SpePharm's management team has an effective strategy in place to become a leading specialty pharmaceutical company, meeting the needs of patients and physicians throughout Europe. Paul Capital Healthcare's investment in SpePharm is consistent with the Fund's mission to provide growth capital to innovative companies. The Fund's investments in SpePharm will help the Company achieve its strategic objectives and underscores Paul Capital Healthcare's commitment to tailoring financial vehicles that meet the unique needs of individual healthcare companies throughout the world."

James Gale, a founding partner and Managing Director of Signet Healthcare Partners commented:

"We are delighted that Paul Capital Healthcare has joined the SpePharm investor group. The Fund's financial commitment to the Company validates the substantial business opportunity for a pan-European specialty pharmaceutical company. SpePharm is taking a leadership position in the market for important therapeutic products with annual sales below euro 100M, which is underserved by large pharmaceutical companies. We believe that SpePharm is very well positioned to create value for patients, healthcare providers and the Company's investors."

Dr. Hubert Birner, General Partner of TVM Capital added:

"The investment by Paul Capital Healthcare will support SpePharm's strategy of growth through active in-licensing and/or M&A. We believe that the extensive business development network provided by Jean-Francois Labbe and his team, Paul Capital Healthcare and the founding investors TVM Capital and Signet HealthCare Partners will yield numerous high value opportunities for SpePharm."

About Paul Capital Healthcare and Paul Capital Partners

Through its funds, Paul Capital Healthcare is one of the largest dedicated healthcare investors globally, with more than $1.5 billion in equity capital commitments and debt facilities under management. Combined, the P
'/>"/>

SOURCE Paul Capital Healthcare
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Quintiles Completes Previously Announced New Investor Partnership, Co-Led by Founder, Chairman and CEO Dennis Gillings, Bain Capital, TPG and 3i
2. Deloitte Agrees to Acquire Recombinant Capital, A Leading Life Sciences Subscription Database and Advisory Services Firm
3. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
4. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
5. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
6. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
7. InterCure and Omron Healthcare (UK) Ltd. Announce Marketing Collaboration for Hypertension Market in United Kingdom
8. Apria Healthcare Chooses Masimo SET Pulse Oximetry for Use in the Companys Home Health Care Business
9. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
10. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
11. Boston Scientific to Participate in the Bear Stearns 20th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... Irvine,CA (PRWEB) , ... August 31, 2015 , ... Proove ... Orange County Technology Alliance Annual High Tech Awards. , Now in its 22nd ... and products which drive innovation here, across the nation and around the world. The ...
(Date:8/28/2015)... Research and Markets ( ... "Global & USA BioSimilar Market Analysis to 2021" ... US Biosimilar market will be initiated in September as ... will the global market react? Will biosimilars explode into ... save the US economy up to $250 billion within ...
(Date:8/28/2015)... , ... August 28, 2015 , ... ... Medicine, presented two studies at the International Spine Intervention Society’ s ... 2015 through to August 1st, 2015. With a focus on evidence-based research and ...
(Date:8/28/2015)... , Aug. 28, 2015 /PRNewswire/ - RepliCel ... stage regenerative medicine company focused on the development ... for the quarter ended June 30, 2015, corporate ... and management report are available at www.sedar.com ... . "RepliCel expects to launch ...
Breaking Biology Technology:Proove Biosciences, Inc. Named a Finalist for 22nd OC Tech Alliance High-Tech Awards for Company of the Year 2Proove Biosciences, Inc. Named a Finalist for 22nd OC Tech Alliance High-Tech Awards for Company of the Year 3Proove Biosciences, Inc. Named a Finalist for 22nd OC Tech Alliance High-Tech Awards for Company of the Year 4Global & USA BioSimilar Market Analysis Report 2015-2021 2Global & USA BioSimilar Market Analysis Report 2015-2021 3Proove Biosciences Presents New Research Study at the International Spine Intervention Society’s Annual Scientific Meeting 2Proove Biosciences Presents New Research Study at the International Spine Intervention Society’s Annual Scientific Meeting 3Proove Biosciences Presents New Research Study at the International Spine Intervention Society’s Annual Scientific Meeting 4RepliCel Reports Second Quarter 2015 Financial Results 2RepliCel Reports Second Quarter 2015 Financial Results 3RepliCel Reports Second Quarter 2015 Financial Results 4RepliCel Reports Second Quarter 2015 Financial Results 5
... 3 BioSpecifics,Technologies Corp. (OTC Bulletin Board: BSTC.OB) ... its common stock priced at $13 per,share with ... purchased by an investment group on May 30, ... PIPE transaction at a premium over the market ...
... 2008 -- GE Energy, manufacturer of Reuter Stokes radiation ... market the electronics and software associated with the SNS ... system of sensitive neutron detectors developed at Oak Ridge ... compact neutron detection system that was developed for the ...
... 14,000 Employees in Industry with Revenues of 7 Billion Swiss ... 300+ Research Groups ... 148 biotech companies and 72,suppliers to the industry -- or ... highest biotech density per capita, reports,Mario Brossi of the foreign ...
Cached Biology Technology:GE Energy to market SNS-developed detector electronics system 2220 Companies Place Switzerland First in Biotech Density Per Capita 2220 Companies Place Switzerland First in Biotech Density Per Capita 3
(Date:8/12/2015)... JOSE, Calif. , Aug. 12, 2015 /PRNewswire/ ... developer of human interface solutions, today announced that ... recently announced Match-in-Sensor solution, have officially been named ... Alliance. As part of the certification, Synaptics, Natural ... FIDO 1.0 Universal Authentication Framework (UAF) standard and ...
(Date:8/6/2015)... BOSTON and TELTOW, Germany ... the 2015 Siggraph Conference, SensoMotoric Instruments (SMI) ... augmented reality , based on Epson,s Moverio ... eye tracking platform. With this new solution, unprecedented quality ... multi-modal, hands-free interaction with context-sensitive displays. For the first ...
(Date:8/4/2015)... , Aug. 04, 2015 ... ) has announced the addition of the ... Software, and Service), Sub-Segment (Computer Forensics, Network ... Tool Types, Service, Vertical and Region - ... their offering. By Component (Hardware, ...
Breaking Biology News(10 mins):Synaptics Announces FIDO Certification of Natural ID Fingerprint Solutions 2Synaptics Announces FIDO Certification of Natural ID Fingerprint Solutions 3SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 2SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 3Digital Forensics Market - The Market Represents a Compound Annual Growth Rate (CAGR) of 11.3% From 2015 to 2020 2
... Putnam Valley, NY. (Aug 22 2013) Multipotent fetal ... cell therapy for repairing damaged tissues and organs. Their ... said a research team in Italy that developed a ... study that appears as an early e-publication for the ...
... (Aug. 22, 2013) Patients receiving cranial irradiation ... life-saving, but often suffer progressive and debilitating cognitive ... cognitive deficits are a contributing factor to the ... quality of life after radiation therapy. ,In an ...
... a paper published by the journal Biodiversity Conservation ... as a powerful tool for promoting low-profile species that ... present, anthropomorphism in conservation is limited to social, intelligent ... to the research, this would imply that other species ...
Cached Biology News:Fetal tissue-derived stem cells may be ideal source for repairing tissues and organs 2Fetal stem cell transplantation favorably impacts radiation-induced cognitive dysfunction 2Relating animals to humans could help conservation projects 2
... is a DNA-dependent RNA polymerase which is ... It efficiently synthesizes in vitro transcripts from ... from a T7 promoter. Transcripts can ... in vitro translation, substrates in RNA processing ...
... ATP: D-hexose 6- phosphotransferase/D-glucose-6-phosphate: NADP ... of HK will phosphorylate 1 ... min at 25C at pH ... will oxidize 1 mol of ...
... an endoribonuclease, the RNA strand of ... origin, e.g. that of phage FX174, ... x poly(dT). RNase H produces ribonucleotides ... no activity is detected with polyribonucleotides ...
Request Info...
Biology Products: